QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Delving into evidence synthesis?
PubMed®, Embase® and Google Scholar – what is the difference and when should I use each?
In the realm of HEOR, synthesizing evidence from diverse sources is crucial for informed decision-making.
Choosing the right database can significantly impact the quality and relevance of your literature search.
Here’s a quick guide to help you understand the differences between PubMed®, Embase®, and Google Scholar, and when to use each.
[…]
Discovering the power of Swedish data🦾
Sweden’s rich data infrastructure and progressive approach to digitalization present a unique opportunity for conducting ground-breaking research.
With a focus on transparency, accessibility, and comprehensive coverage, Swedish real-world data (RWD) is a cornerstone for impactful studies in HEOR.
Here are some key features of the Swedish data landscape:
𝐄𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐢𝐞𝐬
Sweden boasts well-established national registries offering wide-ranging data across healthcare, social services, and education. From patient health records to detailed epidemiological data, […]
This year´s deep dive in swedish access to new medicines is now published on Lif´s webpage!
Every year, Quantify Research supports Lif by providing EFPIA – European Federation of Pharmaceutical Industries and Associations with information needed for the W.A.I.T survey for Sweden, and performs a detailed review of national reimbursement of new medicines.
This year’s cohort of the Swedish deep dive includes new medicines with EMA approval in 2020-2022, with an aim to present […]
Meet our speakers: “How can RWE be used in applications to the Medicines Council?”
Quantify Research is excited to host its next morning meeting on 9 October in Copenhagen.
Denmark has unique registry data, but there is uncertainty about how to best use it to create quality evidence for decision-making.
In this meeting we explore the possibilities in this rapidly evolving area.
Meet our confirmed speakers:
Christian Dehlendorff (Medicinrådet)
Prof Celeste Porsbjerg ( […]